Q: What is Yusimry used for?

Yusimry is used to treat the following conditions: Ankylosing spondylitis Crohn's disease Hidradenitis suppurativa Others

Q: How does Yusimry work?

Targeting Inflammation Yusimry belongs to a class of medications known as tumor necrosis factor (TNF) blockers. TNF is a protein naturally produced by the body's immune system. While it normally helps the body fight infections, people with certain autoimmune diseases often produce too much of it. When TNF levels are too high, the immune system mistakenly attacks healthy tissues, leading to persistent inflammation. This inflammation is responsible for the pain, stiffness, and swelling seen in conditions such as rheumatoid arthritis, plaque psoriasis, and inflammatory bowel diseases. How the Medication Acts Yusimry is a monoclonal antibody, which is a type of protein designed to recognize and bind to a specific target. In this case, the medication binds directly to the excess TNF molecules in the bloodstream and tissues. By latching onto these proteins, Yusimry prevents them from attaching to healthy cells and triggering the inflammatory process. By blocking this pathway, the medication helps to: Reduce swelling and pain in the joints and skin. Slow the progression of joint damage in inflammatory arthritis. Decrease inflammation in the digestive tract for those with bowel diseases. Because Yusimry targets a specific part of the immune system rather than suppressing the entire system, it is considered a biologic therapy. It does not cure the underlying condition but helps manage the symptoms and prevent further tissue damage by keeping the inflammatory response under control.

Q: What are the brand names for Yusimry?

Yusimry is sold under the brand names Humira , Cyltezo , and Amjevita .

Q: What are the active ingredients in Yusimry?

The active ingredient in Yusimry is adalimumab .

Q: What are the side effects of Yusimry?

Common side effects of Yusimry may include: Injection site reactions Upper respiratory infection Headache Always consult with a healthcare professional about potential side effects.

Q: What drug class is Yusimry?

Yusimry belongs to the TNF inhibitor drug class.

Q: Is Yusimry safe during pregnancy and breastfeeding?

Pregnancy Data on the use of Yusimry during pregnancy are limited. Adalimumab, the active ingredient, is known to cross the placenta, particularly during the third trimester. This may influence the immune system of the developing fetus. Healthcare providers typically evaluate whether the benefits of treatment outweigh the potential risks to the pregnancy. If Yusimry is used during pregnancy, it may affect the infant's ability to fight infections. It is generally advised to inform the infant's pediatrician about the exposure, as certain vaccinations, specifically live vaccines, may need to be delayed for several months after birth. Breastfeeding Yusimry is excreted into human breast milk in very small amounts. While it is believed that the medication is mostly destroyed in the infant's stomach and not absorbed into their bloodstream in significant quantities, the long-term effects on a nursing child are not well-established. Decisions regarding breastfeeding while using this medication should be made in consultation with a healthcare professional to weigh the benefits of breastfeeding against any potential risks.

Question 1

What is Yusimry?

Accepted Answer

Yusimry is a tumor necrosis factor (TNF) blocker that belongs to a class of medications known as monoclonal antibodies. It works by binding to TNF-alpha, a substance in the body that causes inflammation, and blocking its action.

This medication is a biological product designed to interfere with the inflammatory process. It is classified as a biosimilar, which means it is highly similar to an existing approved biological reference product.

Question 2

What is Yusimry used for?

Accepted Answer

Yusimry is used to treat the following conditions:

Ankylosing spondylitis
Crohn's disease
Hidradenitis suppurativa
Others

Question 3

How does Yusimry work?

Accepted Answer

Targeting Inflammation

Yusimry belongs to a class of medications known as tumor necrosis factor (TNF) blockers. TNF is a protein naturally produced by the body's immune system. While it normally helps the body fight infections, people with certain autoimmune diseases often produce too much of it.

When TNF levels are too high, the immune system mistakenly attacks healthy tissues, leading to persistent inflammation. This inflammation is responsible for the pain, stiffness, and swelling seen in conditions such as rheumatoid arthritis, plaque psoriasis, and inflammatory bowel diseases.

How the Medication Acts

Yusimry is a monoclonal antibody, which is a type of protein designed to recognize and bind to a specific target. In this case, the medication binds directly to the excess TNF molecules in the bloodstream and tissues. By latching onto these proteins, Yusimry prevents them from attaching to healthy cells and triggering the inflammatory process.

By blocking this pathway, the medication helps to:

Reduce swelling and pain in the joints and skin.
Slow the progression of joint damage in inflammatory arthritis.
Decrease inflammation in the digestive tract for those with bowel diseases.

Because Yusimry targets a specific part of the immune system rather than suppressing the entire system, it is considered a biologic therapy. It does not cure the underlying condition but helps manage the symptoms and prevent further tissue damage by keeping the inflammatory response under control.

Question 4

What are the brand names for Yusimry?

Accepted Answer

Yusimry is sold under the brand names Humira, Cyltezo, and Amjevita.

Question 5

What are the active ingredients in Yusimry?

Accepted Answer

The active ingredient in Yusimry is adalimumab.

Question 6

What are the side effects of Yusimry?

Accepted Answer

Common side effects of Yusimry may include:

Injection site reactions
Upper respiratory infection
Headache

Always consult with a healthcare professional about potential side effects.

Question 7

What drug class is Yusimry?

Accepted Answer

Yusimry belongs to the TNF inhibitor drug class.

Question 8

What is the dosage of Yusimry and how do I take it?

Accepted Answer

How to Use Yusimry

Yusimry is available as a prefilled pen or a prefilled syringe for subcutaneous injection. It is typically injected into the front of the thighs or the abdomen, avoiding the area immediately around the belly button. It is important to rotate the injection site each time you use the medication to reduce the risk of skin reactions.

Preparation

Remove the medication from the refrigerator and let it reach room temperature for about 15 to 30 minutes before injecting. Do not remove the cap while waiting.
Do not heat the medication in a microwave or under hot water.
Check the liquid in the syringe or pen. It should be clear to slightly yellow and free of large particles. Do not use if the liquid is cloudy, discolored, or contains flakes.
Wash your hands thoroughly and clean the injection site with an alcohol swab before administration.

General Administration Guidelines

Do not inject into skin that is tender, bruised, red, hard, or has scars or stretch marks. If you have psoriasis, avoid injecting directly into raised, thick, red, or scaly skin patches. Each pen or syringe is for one-time use only and should be disposed of in a puncture-resistant sharps container.

Missed Dose

If you miss a dose, inject it as soon as you remember. Take your next dose at your regularly scheduled time. Do not use extra medicine to make up for a missed dose.

Question 9

Is Yusimry safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

Data on the use of Yusimry during pregnancy are limited. Adalimumab, the active ingredient, is known to cross the placenta, particularly during the third trimester. This may influence the immune system of the developing fetus. Healthcare providers typically evaluate whether the benefits of treatment outweigh the potential risks to the pregnancy.

If Yusimry is used during pregnancy, it may affect the infant's ability to fight infections. It is generally advised to inform the infant's pediatrician about the exposure, as certain vaccinations, specifically live vaccines, may need to be delayed for several months after birth.

Breastfeeding

Yusimry is excreted into human breast milk in very small amounts. While it is believed that the medication is mostly destroyed in the infant's stomach and not absorbed into their bloodstream in significant quantities, the long-term effects on a nursing child are not well-established. Decisions regarding breastfeeding while using this medication should be made in consultation with a healthcare professional to weigh the benefits of breastfeeding against any potential risks.

Question 10

What forms and strengths does Yusimry come in?

Accepted Answer

Yusimry is supplied as a sterile, preservative-free solution for injection under the skin. It is available in the following delivery formats:

Prefilled Pen: A single-dose, disposable device designed for subcutaneous injection.
Prefilled Syringe: A single-dose, disposable syringe with a fixed needle.

Each device is intended for one-time use only and should be discarded after the dose is administered.

Question 11

What is the FDA approval status of Yusimry?

Accepted Answer

FDA Approval Status

Yusimry (adalimumab-aqvh) is approved by the U.S. Food and Drug Administration (FDA) as a biosimilar to Humira. A biosimilar is a biological medication that is highly similar to an existing FDA-approved biological product, with no clinically meaningful differences in safety, purity, or potency.

Approved Indications

Yusimry is FDA-approved to treat several autoimmune and inflammatory conditions, including:

Rheumatoid arthritis
Juvenile idiopathic arthritis
Psoriatic arthritis
Ankylosing spondylitis
Crohn's disease
Ulcerative colitis
Plaque psoriasis

Boxed Warning

The FDA has issued a boxed warning for Yusimry regarding the following risks:

Serious Infections: Patients are at an increased risk for developing serious infections that may lead to hospitalization or death. These include tuberculosis (TB), bacterial sepsis, and invasive fungal infections.
Malignancy: Lymphoma and other malignancies, some of which have been fatal, have occurred in children and adolescent patients treated with tumor necrosis factor (TNF) blockers.

Question 12

What should I know about Yusimry and cost?

Accepted Answer

Insurance and Out-of-Pocket Costs

The amount you pay for Yusimry is primarily determined by your insurance plan. Most commercial insurance plans and government programs like Medicare or Medicaid provide coverage for adalimumab products, but the specific tier and co-payment amount can vary. Many insurers require prior authorization before approving coverage for this medication.

Biosimilar Savings

Yusimry is a biosimilar to the reference product Humira. Biosimilars are highly similar biological products that are typically offered at a lower cost than the original brand-name drug. Choosing a biosimilar may result in lower costs for both patients and healthcare systems.

Financial Assistance

Financial support may be available to help manage the cost of Yusimry:

Co-pay Savings: Eligible patients with commercial insurance may be able to use a co-pay card from the manufacturer to reduce their out-of-pocket expenses.
Patient Assistance: Programs may exist for patients who lack insurance or have limited coverage, providing the medication at a reduced cost based on financial need.

It is recommended to contact your insurance provider and the specialty pharmacy to get an accurate estimate of your specific costs.

Yusimry

📋Overview

How It Works

Uses

Brand Names

Active Ingredients

Common Side Effects

Warnings & Precautions

Dosage

Pregnancy & Breastfeeding

Frequently Asked Questions

📚References

Found an Error?

Find Discounts for Yusimry

Hospitals.net Disclosure